GSK moves data management to India
GlaxoSmithKline (GSK) has announced plans to outsource all its data management and medical trial and regulatory reporting functions to India in a deal said to be worth over £10m (€14.7m).
GlaxoSmithKline (GSK) has announced plans to outsource all its data management and medical trial and regulatory reporting functions to India in a deal said to be worth over £10m (€14.7m).
Patheon, Kendle, Charles River, Cetero, Parexel and Asterand have all had people on the move in the world of pharmaceutical outsourcing.
The FDA is giving contract research organisations (CROs) the chance to take part in a pilot designed to test the viability of electronic case report forms (eCRF).